Dry Powder Nasal Sprays a Hot Topic at RDD
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Malvern Instruments Inc.
117 Flanders Rd.
Westborough, MA, 01581
Press release date: June 9, 2011
Malvern/NextBreath workshop generates lively debate
09 June 2011 - Malvern, UK - Laser diffraction particle size analysis, already widely used in the characterization of a variety of OINDPs (orally inhaled and nasal drug products) is proving its value in the development of some of the newest drug delivery formulations - dry powder nasal sprays. This was the conclusion of a well-attended workshop on 'Characterizing the Performance of Nasal Dry Powder Devices' presented by Dr Paul Kippax, from Malvern Instruments, and Dr Julie Suman, President of NextBreath LLC, during May's Respiratory Drug Delivery Europe 2011 (RDD 2011) conference in Berlin, Germany.
"Over the past few years, there has been increased interest in the use of nasal dry powder delivery systems for a variety of therapies but to date there is no clear guidance on how these should be characterized," said Paul Kippax. "At Malvern we have considerable know-how and experience in characterizing standard nasal spray products, and our recent research with NextBreath has shown that techniques applied to liquid systems are appropriate for characterizing nasal dry powder devices."
The workshop considered whether the characterization techniques applied to liquid-based nasal spray formulations for in vitro bioequivalence and bioavailability assessments may also be used to understand the performance of dry powder devices. It focused on how measurements using laser diffraction and plume imaging provide a means of understanding powder dispersion and deposition behaviour. Malvern's Spraytec laser diffraction analyzer, for example, performs extremely rapid measurements and can be used to observe plume evolution and monitor the changes in concentration which occur as a device is actuated. www.malvern.com/spraytec_oindp
Attention was also paid to how emerging methods, such as combined automated image analysis and Raman spectroscopy (Morphologi G3-ID), can provide drug-specific metrics for device and formulation performance, and a more complete assessment of API dispersion. The Morphologi G3-ID enables the classification of particles based on size and shape parameters, followed by the acquisition of Raman spectra of targeted particles for further classification based on chemistry. www.malvern.com/morphologi
About Malvern Instruments
Malvern Instruments is a market leader in measuring performance controlling material properties. These include particle size, particle shape, zeta potential, molecular weight, size and conformation, rheological properties and chemical identification. Malvern delivers the systems, support and expertise that ensure the analytical integrity and productivity needed to drive research, development and manufacturing.
Malvern's measurement solutions for scientists, technologists and engineers advance continually through customer collaboration. Complementary materials characterization systems deliver inter-related measurements that reflect the complexities of particulates and disperse systems, nanomaterials and macromolecules. Combining intelligently implemented technologies with in-depth industry applications knowledge and support, Malvern provides customers with the competitive advantage they demand.
Headquartered in Malvern, UK, Malvern Instruments has subsidiary organizations in all major European markets, North America, China, Japan and Korea, a joint venture in India, a global distributor network and applications laboratories around the world. www.malvern.com
Marisa Fraser, Malvern Instruments Inc.
117 Flanders Road, Westborough, MA 01581-1042 USA
Tel: +1 508 768 6400 Fax: +1 508 768 6403 firstname.lastname@example.org